Tumbleweed Raises €6.9M Seed to Expand Commercial Microgravity Research | Page 7
Tumbleweed raises €6.9M Seed to fund three orbital missions in 2027 and develop Oasis Beta, a platform designed to return research samples from space.
Latest articles
5 min
INSEAD AI Founder Sprint 2027 Opens Applications for Early-Stage Founders
INSEAD AI Venture Lab opens applications for its free 10-week AI Founder Sprint 2027.
2 min
Sava Raises $36M Series B and Signs European Glucose Monitoring Deal With Ascensia
Sava raises $36M Series B led by Ascensia to scale its glucose microsensor technology and prepare for a European commercial launch.
2 min
Hiver Launches Hiver Omni, an AI-Powered Platform for Complex Customer Support
Hiver launches Hiver Omni, an AI-powered platform that automates complex customer support workflows across multiple channels and business systems.
3 min
Testlio Joins OpenAI Partner Network as Select Partner for AI Testing
Testlio becomes an OpenAI Select Partner, expanding its work in human-led testing of AI applications and agents across global markets.
2 min
Rein Security Raises $25M Series A to Protect Enterprise AI Agent
Rein Security raises $25M Series A to expand its AI agent security platform after reporting eightfold revenue growth since January 2026.
2 min
TODAY Raises €2.8M Seed to Automate Financial Advisors’ Workflows With AI
TODAY raises €2.8M Seed to expand its AI platform for financial advisors, already used by more than 3,500 professionals across DACH.
2 min
Agentiq Sports Raises $4M to Let Fans Invest in Professional Athletes
Agentiq Sports raises $4M to launch a platform allowing fans to invest indirectly in professional athletes’ future on-field brand income.
2 min
28th Connected Banking Summit to Bring Southern African Banking Leaders to Johannesburg
ICSA hosts the 28th Connected Banking Summit on 14 Oct 2026 in Johannesburg, bringing banking leaders together on AI, security and digital finance.
1 min
WhiteLab Genomics Raises $26M Series B for AI-Designed Genomic Medicines
WhiteLab Genomics raises $26M Series B to expand its AI-designed genomic medicines and in vivo validation across global markets.